News | June 30, 2025
Biocon Biologics expands insulin access in Malaysia
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
Over 100 million cartridges of rh-insulin supplied to Malaysian health ministry; 345,000+ patients served
The program will start with providing bTrastuzumab to cancer patients facing treatment delays due to budget constraints
Lexicon Pharmaceuticals announces exclusive license agreement with Novo Nordisk for LX9851
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Offers affordable, high-quality solutions for diabetes care
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Akums Drugs & Pharmaceuticals has launched Dapagliflozin + Pioglitazone tablets, a dual-action therapy for diabetes management
Prithwish has close to 28 years of experience in a Commercial role
The huminsulin range of products is indicated for the treatment of type 1 and type 2 diabetes mellitus to improve blood sugar control in both adults and childre
Afrezza, developed by MannKind Corporation in the USA, offers a needle-free, rapid-acting insulin option for diabetes management
Subscribe To Our Newsletter & Stay Updated
